WAP
IHE icon

Wealthcare Advisory Partners’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Wealthcare Advisory Partners’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$493K Buy
4,976
+4
+0.1% +$360 0.01% 715
2026
Q1 		$431K Sell
4,972
-154
-3% -$13.5K 0.01% 753
2025
Q4 		$435K Buy
5,126
+11
+0.2% +$878 0.01% 740
2025
Q3 		$371K Buy
5,115
+217
+4% +$15K 0.01% 767
2025
Q2 		$321K Buy
4,898
+201
+4% +$13.1K 0.01% 769
2025
Q1 		$331K Sell
4,697
-481
-9% -$33.4K 0.01% 706
2024
Q4 		$340K Buy
5,178
+675
+15% +$46.4K 0.01% 670
2024
Q3 		$318K Buy
4,503
+594
+15% +$41.4K 0.01% 700
2024
Q2 		$259K Buy
3,909
+7
+0.2% +$459 0.01% 722
2024
Q1 		$265K Buy
+3,902
New +$258K 0.01% 708

Other funds holding IHE

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return
MCM
Monument Capital Management Alexandria, Virginia $497M AUM 52.58% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
FP
FFG Partners Fort Lauderdale, Florida $352M AUM 70.53% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
AFG
Arkansas Financial Group Little Rock, Arkansas $768M AUM 16.55% 1-Year Est. Return
HCMT
Highland Capital Management (Tennessee) Memphis, Tennessee $2.17B AUM 54.74% 1-Year Est. Return
SIA
SeaBridge Investment Advisors Summit, New Jersey $692M AUM 52.26% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Wealthcare Advisory Partners's IHE Position: Q2 2026 in Review

Wealthcare Advisory Partners increased its iShares US Pharmaceuticals ETF (IHE) stake by 0.08% in Q2 2026, buying an estimated $360 and bringing the position to 4,976 shares worth $493K. The position accounts for 0.01% of the portfolio, ranked #715.

Wealthcare Advisory Partners first reported a position in IHE in Q1 2024 and has held it in 10 quarters since. 40 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • Wealthcare Advisory Partners held 4,976 shares of iShares US Pharmaceuticals ETF worth $493K as of Q2 2026.
  • Wealthcare Advisory Partners bought 4 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $360.
  • iShares US Pharmaceuticals ETF made up 0.01% of Wealthcare Advisory Partners's portfolio in Q2 2026, its #715 holding.
  • Wealthcare Advisory Partners first reported a position in iShares US Pharmaceuticals ETF in Q1 2024 and has held it in 10 quarters since.
  • 40 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.